Keloid. Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: treatment with plasma plexer device without triamcinolone injection. Intervention 2: Control group: treatment with plasma plexer device is performed with triamcinol
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The minimum age is 18 and the maximum age is 70 years Informed consent to participate in the study People who have the possibility of follow-up after treatment People who have a keloid scar with a maximum height of 5 mm
Exclusion criteria
Exclusion criteria: Pregnant or lactating patients and children under 15 years old due to the possible side effects of triamcinolone People who have had a history of treatment at the site of the lesion in the last 6 months People who have any type of underlying disease that affects wound healing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Keloid recovery. Timepoint: Between 2 and 5 sessions with an interval of one month. Method of measurement: doctor checkup.;Patient satisfaction. Timepoint: After treatment (after 2 to 5 sessions). Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSepideh Tehrani
Islamic Azad University
Outcome results
None listed